ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors

NEXT STORY
Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program
PREV STORY
Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Protalix BioTherapeutics Presents Positive Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 1st Canadian Symposium on Lysosomal Diseases 2018

~Preliminary Results Indicate Significant Improvement in Kidney Function in Patients Switched from agalsidase alfa ...

author_avatar
NASDAQ Market News

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

GeoVax and PharmaJet to Collaborate On Development of Needle-Free Vaccine for Zika Virus

GeoVax Zika Virus Vaccine Provided 100% Protection in Animal Challenge Model ATLANTA, GA, Aug. ...

author_avatar
NASDAQ Market News